The human microbiome, asthma, and allergy by Amund Riiser
Riiser  Allergy Asthma Clin Immunol  (2015) 11:35 
DOI 10.1186/s13223-015-0102-0
REVIEW




The human microbiome can be defined as the microorganisms that reside within and on our bodies and how they 
interact with the environment. Recent research suggests that numerous mutually beneficial interactions occur 
between a human and their microbiome, including those that are essential for good health. Modern microbiological 
detection techniques have contributed to new knowledge about microorganisms in their human environment. These 
findings reveal that the microbiomes of the lung and gut contribute to the pathogenesis of asthma and allergy. For 
example, evidence indicates that the microbiome of the gut regulates the activities of helper T cell subsets (Th1 and 
Th2) that affect the development of immune tolerance. Moreover, recent studies demonstrate differences between 
the lung microbiomes of healthy and asthmatic subjects. The hygiene and biodiversity hypotheses explain how 
exposure to microorganisms is associated with asthma and allergy. Although those living in developed countries are 
exposed to fewer and less diverse microorganisms compared with the inhabitants of developing countries, they are 
experiencing an increase in the incidence of asthma and allergies. Detailed analyses of the human microbiome, as 
are being conducted under the auspices of the Human Microbiome Project initiated in 2007, promise to contribute 
insights into the mechanisms and factors that cause asthma and allergy that may lead to the development of strate-
gies to prevent and treat these diseases.
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Background
Microbiomes exist in numerous diverse environments 
such as soil, freshwater, and seawater. The human micro-
biome was studied for the first time in the 1600s when 
Antonie van Leeuwenhoek scraped the coating of his 
teeth and studied the contents using his self-fabricated 
microscope [1]. Just over 300 years later, the Nobel Lau-
reate Joshua Lederberg coined the term “the human 
microbiome” to describe the ecological community of 
symbiotic and pathogenic microorganisms that inhabit 
the body [2]. Lederberg believed that microorganisms 
in the human body are significant for health and disease 
[2]. Scholars distinguish between the concepts of micro-
biome [3, 4] and microbiota [5] to separate the collective 
genomes of microorganisms from the microorganisms 
themselves, although the original definitions do not dis-
tinguish between them [3–5].
An adult human harbors approximately 100 billion bac-
teria in the intestine alone, and the microbiome accounts 
for 90 % of the cells in the human body [3]. The human 
genome comprises about 21,000 genes that encode pro-
teins [6]. In contrast, the microbiome may comprise 
approximately three million genes [4]. The microbiome 
may be considered a “new organ system,” because its 
existence and contributions to human health and disease 
was uncovered by researchers between 15 and 20  years 
ago [7]. The composition and function of the microbi-
ome of the human gut evolves during the first years of 
life and stabilize within the first 3  years of life [8–10]. 
The development of the gut microbiome is influenced by 
interactions between diet, environment, and host- and 
microbe-associated factors [10–18]. The gut microbi-
ome plays a fundamental role in shaping host immunity 
by balancing the activities of Th-1 cells and Th-2 cells 
[19–23]. In contrast to the extensive knowledge of the 
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gut microbiome [11, 24], information on the lung micro-
biome is limited [25, 26]. However evidence suggests a 
distinct microbiome of the lungs of healthy subjects [27] 
and a difference between the microbiomes of healthy 
people and those with obstructive lung diseases such as 
asthma [28].
The aim of the present review was to provide a general 
account of current research on the gut and lung microbi-
omes of humans and their association with the pathogen-
esis of allergy and asthma.
Review
The human microbiome
Over the last 30  years, the development of techniques 
to sequence microbial ribosomal RNA genes has led to 
the reconstruction of the evolutionary history of micro-
organisms [29, 30] and the illumination of their ecology. 
The United States National Institutes of Health initi-
ated the Human Microbiome Project (HMP), which was 
allocated a budget of 150 million USD to investigate 
the microbiota of the human nose, mouth, gut, skin, 
and genitourinary tract with the aim of documenting 
the changes in the microbiome associated with human 
health [4]. Contributions of the HMP include the discov-
ery that the microbiomes of the anatomic sites described 
above are similar among individuals but vary between 
the hair, nose, mouth, gut, skin, and genitourinary tract 
[24]. However, there may be large individual variations in 
microbiomes at the same sites on the body among indi-
vidual [31].
The gut microbiome
The most thoroughly studied microbiome is that of the 
human gut [26]. Swift adaptation to modern lifestyles 
and environmental transitions likely changed the human 
gut microbiome with clear effects on immunological and 
physiological processes that affect human health [11]. 
The stability and diversity of the gut microbiome increase 
over the first 3  years of life [8–10]. Perinatal exposure 
[14], gestational age [16], mode of delivery [12], host 
genetics [15], and breastfeeding [10, 13] influence the 
development of the microbiomes of infants while antibi-
otics [18] and diet may also influence the microbiomes of 
older people [17]. Firmicutes and Bacteroidetes dominate 
the gut microbiome of adults; however, the representa-
tion and diversity of different classes of bacteria vary 
enormously [4].
A recent study of fecal samples of 124 European sub-
jects identified between 1000 and 1150 bacterial species. 
Each individual in the cohort harbored at least 160 bacte-
rial species, many of which were shared [32]. Knowledge 
gained from research on the gut microbiome provides 
insight into the development of allergic diseases and 
why the far less studied lung microbiome may contribute 
to the development of asthma. Factors such as birth by 
cesarean section [12, 33], breastfeeding [33], introduction 
of solid foods [10], and use of antibiotics by the mother 
or infant [34] affect the gut microbiome and are associ-
ated with increased incidences of asthma and allergies 
[35]. For example in a study including 2733 1-month-old 
infants, colonization of with Clostridium difficile is asso-
ciated with birth by cesarean section and an increase in 
the risk of asthma (aOR =  2.06) at 6  years of age [36]. 
However, there are great inconsistencies in the findings 
of studies on the association between delivery by caesar-
ian section and proven food allergy [37].
However, there is persuasive evidence indicating that 
children born by cesarean section have twice the risk of 
being sensitized to egg and milk allergens [38]. A recent 
study [40] of the association between gut microbiota 
and food sensitization in the first year of life among 166 
infants found that 7.2 % were sensitized to one or more 
food allergens at 1 year of age and had lower gut microbi-
ota richness and an elevated Enterobacteriaceae:Bacterioi
daceae ratio. These findings suggest that early gut coloni-
zation may contribute to the development of atopic dis-
eases such as food allergy [39]. Interaction between the 
host and the gut microbiome may explain the relation-
ship between the microbiome and asthma and allergies.
Studies conducted using mice show that the gut micro-
biome is important in shaping the host’s immune system 
[23]. Mice with different genetic predispositions to polar-
ize responses to different antigens in opposite directions, 
toward either Th1 cells (possibly suppressed in asthma 
and allergy [40]) or Th2 cells (enhanced in asthma and 
allergy [40]) depending on the stimulus, both have air-
way response when the microbiome is disrupted [41]. By 
controlling the activation of antigen-presenting dendritic 
cells in the gut, single bacterial species may regulate the 
differentiation of naïve T cells into regulatory T cells [20]. 
The microbiome may affect the balance between Th1 
cells and Th2 cells and thus the outcomes of subsequent 
infections with pathogens [20]. This is just one of many 
examples of immune regulation in symbiosis with bac-
teria [17, 19]. Further, specific bacterial species directly 
influence the development of regulatory T cells in mice 
[21] and humans [22]. Thus, symbiotic bacteria may reg-
ulate the immune system.
The lung microbiome
Researchers believed mistakenly for many years that 
the lungs are sterile [42]. For example, in a study of 28 
healthy adults, the most common phyla detected in the 
nose and oropharynx are Actinobacteria, Bacteroidetes, 
Firmicutes, and Proteobacteria and that 2000 bacterial 
genomes per cm2 are present in the upper left lobe of the 
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lung [26]. Proteobacteria, particularly Haemophilus spp., 
are more common in the lungs of asthmatic adults than 
in those of healthy controls who harbor a higher propor-
tion of Bacteroidetes. Further, the abundance of Proteo-
bacteria in asthmatic children is higher compared with 
healthy controls [28].
In children with asthma, the bacterial load is signifi-
cantly higher in the lung compared with healthy con-
trols [44]. Further, Airway microbiological diversity in 
the lungs was significantly greater in asthmatic children 
who demonstrated significant reduction in bronchial 
responsiveness after antibiotic treatment [43]. Six weeks 
of treatment of patients with asthma with azithromycin 
reduces the relative abundance of Prevotella from 4.54 to 
3.43 %, Staphylococcus from 10.49 to 4.59 %, and Haemo-
philus from 10.74 to 3.28 %. In some patients treatment 
with azithromycin reduces the bacterial richness in the 
airways and Anaerococcus becomes the most abundant 
bacteria. [44]. Further research is required to understand 
the role of the lung microbiome in the pathogenesis of 
asthma.
The microbiome in allergy and asthma
Increasing evidence suggests that the compositions of the 
lung and gut microbiomes determine the risk of asthma 
and allergies. It is interesting to consider how these find-
ings support or contradict the “hygiene” and “biodi-
versity” hypotheses (see below) that were proposed to 
account for the influence of the human microbiota on 
allergies and immune tolerance. The hygiene hypothesis 
argues that the lack of early exposure to infectious agents, 
symbiotic microorganisms (such as intestinal flora and 
probiotics), and parasites increases susceptibility to aller-
gic diseases through insufficient stimulation of Th1 cells 
[45], which cannot counterbalance the effects of Th2 
cells, leading to predisposition to allergic diseases [20]. 
The biodiversity hypothesis suggests that disturbances 
in the composition of the gut microbiome of citizens of 
western countries induced by antibiotics, diet, and life-
style disrupt the mechanisms of mucosal immunological 
tolerance [46]. The biodiversity hypothesis extends the 
hygiene hypothesis by stating that the gut microbiome 
interacts with the immune system to maintain the effi-
ciency of the immune system [47].
The hygiene hypothesis
The hygiene hypothesis was proposed to explain the 
invers association between the risk of hay fever and the 
number of older siblings [46]. Thus, infections in early 
childhood transmitted through unhygienic contact with 
older siblings, or through the mother who is infected by 
her older children, prevent the development of allergic 
disease [45]. This hypothesis is supported by the findings 
of a study on school children in areas of Germany that 
were formerly East and West Germany that showed a 
decreased risk of allergic sensitization with an increas-
ing number of older siblings, which was indicated by a 
rate of allergic sensitization this was three times higher 
in the former West compared with East Germany [48]. 
Numerous subsequent cross-sectional studies support 
the hygiene hypothesis, because they show that increased 
exposure to bacteria, fungi, airway infections, dogs, 
cats, and other animals in childhood is associated with 
decreased risk of asthma and allergies [49, 50]. Other 
studies show a lower incidence of allergic diseases in chil-
dren raised on farms [51].
The hygiene hypothesis has been “updated” based on 
cross-sectional data together with experimental data 
and can be reconciled by a “new hygienic hypothesis” 
or a “Western lifestyle hypothesis,” [52] which proposes 
that Th1 cells are not stimulated to balance the Th2 cells. 
Imbalance in the Th2 cell population leads to the produc-
tion of interleukins (IL-4 and IL-5), which then induce 
the production IgE and eosinophils that cause atopic 
disease [53]. The relationship between exposure to differ-
ent types of bacteria or fungi and asthma in children was 
assessed in a review of the characteristics of more than 
15,000 children included in two different studies [50]. 
This analysis found that children who lived on a farm are 
exposed to diverse microflora compared to children not 
living on farms. The two studies analyzed show a reduced 
prevalence of asthma in children who live on a farm com-
pared children not living on farms and an inverse asso-
ciation between exposure to microbes and the probability 
of asthma. However, a correlation between exposure to 
the microbiota and antigen-specific IgE was not detected 
[49].
Because cross-sectional studies simultaneously meas-
ure exposure and effect, they cannot establish a causal 
relationship. For example, the findings of cross-sectional 
studies may be explained if the parents of children with 
atopic disease have fewer children compared with other 
parents. Thus, the lower incidence of asthma and aller-
gies in people who live on farms may be explained by 
families with asthma who discontinue farming and move; 
in contrast, healthy families continue to farm. Such 
an effect is called the healthy worker effect [54]. Occu-
pational epidemiology studies suggest that the healthy 
worker effect reduces the association between exposure 
and outcome by 20–30 % [55] and that the effect of “cat 
avoidance” could correspond to a protective effect with 
an odds ratio of 0.83 [56]. Several longitudinal studies 
did not detect similar effects that support the hygiene 
hypothesis [57, 58], and several studies of birth cohorts 
show an positive association between exposure to cats 
and cat allergen-specific IgE [59, 60]. Other observations 
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such as increased atopy in poor and densely populated 
urban areas and among children in kindergarten argue 
against the hygiene hypothesis [61].
The biodiversity and the microflora hypotheses
Biodiversity is important for human livelihood and develop-
ment and plays a paramount role in the quality of life of pop-
ulations worldwide [62]. Moreover, the loss of biodiversity 
may have serious implications for human health [63]. Evi-
dence indicates that the diversity of the body’s microbiota is 
negatively associated with the risk of developing asthma and 
allergy [46, 64]. The biodiversity and disappearing micro-
biota hypotheses argue that changes in how people interact 
with the environment reduces exposure to microorganisms 
and that this may affect the mechanisms of development of 
immunologic tolerance [46, 65]. For example, consumption 
by mothers and infants of untreated cow’s milk is negatively 
associated with asthma and allergies in children regard-
less of whether they live on a farm [66]. Further, a diverse 
intestinal flora in early life is associated with reduced risk 
of allergy at 5 years of age [67], and the diversity of gram-
negative Gammaproteobacteria, common in soil but par-
ticularly dominant in aboveground vegetation, is reduced 
on the skin the atopic adolescents [68]. The association of 
gram-negative Gammaproteobacteria such as Acinetobacter 
with atopic disease is supported by the positive correlation 
of the levels of a regulator of immune tolerance, IL-10, with 
the abundance of Acinetobacter on the skin of healthy but 
not atopic adolescents [68].
The microflora hypothesis extends the hygiene and 
biodiversity hypotheses by proposing that the gut micro-
biome interacts with the immune system to maintain 
immune function. An imbalance in the gut microbiome 
caused by changes in the use of antibiotics and in the 
diet over the last three decades may cause dysfunction of 
the immune system [47]. This may explain why diseases 
such as asthma and allergy develop at any age. The evi-
dence supporting the microflora hypothesis includes the 
increased incidences of asthma and allergies in indus-
trialized countries during the last 50  years [69, 70] and 
includes the major relationships as follows: (1) correla-
tion between allergic diseases and antibiotic use [71, 72], 
(2) correlation between allergic diseases and altered fecal 
microbiota [73, 74], and (3) correlation between aller-
gic diseases and dietary changes [75]. Studies of mice 
demonstrate that antibiotic treatment that disrupts the 
microbiome may inhibit airway tolerance to airborne 
allergens such as fungal spores (e.g. Aspergillus fumiga-
tus) [76] or aerosolized ovalbumin [41].
Probiotics
Probiotics are defined as viable microorganisms that 
enhance the host’s health [77]. There is great uncertainty 
about the efficacy of probiotics for preventing and treat-
ing asthma and allergies. For example, when Lactoba-
cillus was administered prenatally to mothers with at 
least one relative or partner with allergic rhinitis, atopic 
eczema, or asthma, and postnatally for 6 months to their 
infants, the outcome indicated a promising effect on the 
prevention of atopic disease [78]; however, the results of 
more recent studies (mainly of Lactobacillus and Bifido-
bacterium) are inconsistent [79]. A meta-analysis of 25 
studies that assessed the effects of probiotic administra-
tion in children on atopy and asthma found that admin-
istration of probiotics reduces IgE levels and the risk of 
atopic sensitization but not the risk of asthma or wheez-
ing [80]. The timing of ingestion, prenatally to the mother 
and postnatally to the infant versus postnatally to only the 
infant, did not influence IgE levels; however, the risk of 
allergic sensitization was significantly reduced only when 
the administration of probiotics commenced prenatally 
and continued after birth. The decrease in total IgE was 
more pronounced when probiotics were administered for 
longer, and the reduced risk of allergic sensitization may 
therefore depend on the specific bacterial strains. These 
findings indicate that administration of probiotics during 
pregnancy and to infants may contribute to the preven-
tion of atopic diseases in high-risk infants [80].
Bacterial products may have great potential for pre-
venting and treating allergies, although the bacterial 
species, their numbers, and the duration and timing of 
treatment that are safe and effective are unknown [46]. 
The results of a controlled clinical trial of newborns indi-
cate that 6 months of treatment with oral probiotics pro-
tects against IgE-associated dermatitis at 2 years, but only 
for those at high risk of eczema. The effect disappears 
after 5 years of age [81]. Future probiotic supplements are 
likely to contain a wide range of microbes that can have 
long-term beneficial effects on the immune system [82]. 
Therefore, immunological, epidemiological, microbiolog-
ical, and clinical studies are required to establish whether 
supplementation with bacterial products contribute to 
effective treatment and prevention of asthma and allergy. 
Future trials investigating the effects of probiotics should 
include analyses of specific strains of probiotic bacteria 
and longer follow-up.
Areas for future exploration
Allergy and asthma are heterogeneous diseases but 
are categorized according to an increased tendency of 
inflammation driven by changes in the environment, 
nutrition, the gut microbiome, and possibly the lung 
microbiome. The outcome of these changes may depend 
on genotype [83, 84], overall biodiversity [46], and other 
risk factors such as physical activity [85] and air pollution 
[86]. The findings may contribute a common explanation 
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of why the incidence of numerous inflammatory condi-
tions such as asthma and allergy has increased in parallel 
with changes in the environment [11]. A broad inter-
disciplinary approach will be required to understand 
the complex pathogenesis of asthma and allergy and 
to understand the roles of the lung and gut microbi-
omes. The use of standardized outcomes and method-
ology may help address the gaps in our knowledge [11, 
87]. For example, researchers should continue to focus 
on the functional and ecologic characteristics of the gut 
and lung microbiomes of healthy people as well as the 
features of the lung and gut microbiomes of patients 
with specific diseases. The development of strategies to 
improve microbiome colonization patterns will likely 
enhance health throughout an individual’s life. It will be 
necessary to determine if variations in the microbiome 
are the cause or effect of allergies and asthma, and longi-
tudinal studies are essential to control for different con-
founding factors. Further research on the microbiome 
should include organisms other than bacteria as some 
viruses [88] and fungi [89] interact with their hosts cells 
similar to what’s observed with bacteria and their host. 
The results of such research can be ultimately translated 
to the clinic to improve diagnostics as well as treatment 
and prevention strategies that might include probiotics as 
well as dietary and lifestyle interventions.
Conclusions
The microbiome can be defined as all microorganisms 
that inhabit humans and their interactions with the envi-
ronment. The findings of studies employing recently 
developed techniques such as metagenomics as well as 
those of epidemiological studies indicate that humans 
are exposed to fewer microorganisms because of changes 
in factors such as the use of antibiotics and diet, which 
are accompanied by increasing susceptibility to asthma 
and allergies. Moreover, these studies illuminate the dif-
ferences in the microbiomes of healthy people and those 
with asthma and allergies. Moreover, they show that early 
exposure to bacteria may protect against these diseases. 
Further basic studies are required to characterize the 
lung and the gut microbiomes of healthy people was well 
as those with asthma and allergies. The ultimate goal is 
to understand whether aspects of the microbiome are 
linked to disease and whether manipulation of the micro-
biome will be useful to preserve lung function, prevent, 
and treat allergies.
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